Qube Research & Technologies (QRT)’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-308,706
Closed -$2.1M 3902
2025
Q3
$2.1M Sell
308,706
-631
-0.2% -$5.21K ﹤0.01% 2222
2025
Q2
$4.21M Buy
309,337
+229,781
+289% +$2.17M ﹤0.01% 1814
2025
Q1
$433K Sell
79,556
-244,930
-75% -$1.39M ﹤0.01% 2592
2024
Q4
$1.61M Sell
324,486
-80,243
-20% -$421K ﹤0.01% 1971
2024
Q3
$2.12M Sell
404,729
-48,411
-11% -$279K ﹤0.01% 1743
2024
Q2
$3.11M Sell
453,140
-10,774
-2% -$98.6K ﹤0.01% 1458
2024
Q1
$4.77M Buy
463,914
+126,322
+37% +$934K 0.01% 1259
2023
Q4
$2.8M Buy
337,592
+330,696
+4,795% +$2.38M 0.01% 1358
2023
Q3
$43.1K Buy
+6,896
New +$29.9K ﹤0.01% 2914

Other funds holding LFMD

Qube Research & Technologies (QRT)'s LFMD Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of LifeMD (LFMD) in Q4 2025, closing a stake of 308,706 shares — an estimated $2.1M sold.

Qube Research & Technologies (QRT) first reported a position in LFMD in Q3 2023 and held it in 9 quarters. The position peaked at $4.77M in Q1 2024. 104 funds tracked by Wall St. Rank hold LFMD as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining LifeMD position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 308,706 LifeMD shares in Q4 2025, an estimated $2.1M.
  • Qube Research & Technologies (QRT) first reported a position in LifeMD in Q3 2023 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s LifeMD position peaked at $4.77M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held LifeMD as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.